Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • feralBiologist
    Member
    • Jun 2011
    • 61

    #1

    edgeR: fold change reported by exactTest for zero values of rna-seq

    I have used the exact test in edgeR to compute the log fold changes. Here is the snippet:

    Code:
    d <- DGEList(counts=counts, group=samples$Condition)
    d <- calcNormFactors(d)
    d <- estimateCommonDisp(d)
    d <- estimateTagwiseDisp(d)
    de <- exactTest(d)
    I've noticed that some genes have zero expression in all samples belonging to one of the two conditions. This would make the fold change mathematically undefined (division by zero). Yet the FC is reported as being ~2^-9. My question is - how does edgeR come up with this value? I've checked both the manual and the reference guide but couldn't figure out. There are various functions that accept pseudocounts as parameters but I have entered none in my snippet. So how does edgeR make up for the zero values in this particular case (which seems to be the default usage of the exactTest)?
  • rskr
    Senior Member
    • Oct 2010
    • 249

    #2
    Good numerical analysts and mathematicians do delta epsilon proofs to figure out what a mathematically undefined quantity should be in specific cases to provide continuity, then redefine the definition in a specific instance. For example a correlation between two sets with zero variance, isn't defined, division by zero, but it's pretty obvious that a value of 1.0 or perfect correlation makes the most sense when doing hierarchical clustering.

    A more general issue is that using fold changes is likely to amplify noise.

    Comment

    • feralBiologist
      Member
      • Jun 2011
      • 61

      #3
      Thanks, rskr.

      After closer inspection, exactTest seems to be using predFC function which, by default, adds a pseudocount of 0.125 to all observations. This seems to answer it. It would be, perhaps, more transparent to have this as a parameter in exactTest itself but once you dig in the documentation it becomes clear anyway.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      17 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...